NCT04479969

Brief Summary

The purpose of this study is to test an existing home-based pulmonary rehab program with the addition of video chat and a capability of a Spanish version.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
9

participants targeted

Target at below P25 for not_applicable chronic-obstructive-pulmonary-disease

Timeline
Completed

Started Mar 2021

Shorter than P25 for not_applicable chronic-obstructive-pulmonary-disease

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 17, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 21, 2020

Completed
8 months until next milestone

Study Start

First participant enrolled

March 22, 2021

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2021

Completed
Last Updated

July 8, 2022

Status Verified

July 1, 2022

Enrollment Period

4 months

First QC Date

July 17, 2020

Last Update Submit

July 7, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Qualitative Interview

    A Qualitative Interview will be conducted over the phone asking about the video chat experience.

    Week 1

Study Arms (1)

Intervention

OTHER

This is a small study to assess the usability of video conferencing. A total of 10 patients will be enrolled, 5 of which will be Spanish speakers. All patients will test the video conferencing.

Behavioral: Video Chat

Interventions

Video ChatBEHAVIORAL

Video chat with health coach using a computer tablet.

Intervention

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients must be ≥ 40 years old.
  • Patients mist have a diagnosis of GOLD stage II, III, or IV COPD documented by pulmonary function testing.
  • Patients must be a current or previous smoker with at least 10 pack-years of cigarette smoking.
  • Be a native Spanish speaker.

You may not qualify if:

  • Patients with a high likelihood of being lost to follow-up or contact (patients with active chemical dependency).
  • Patients planning to move out of the state or who are not living in the healthcare area.
  • Patients with an inability to provide good data or follow commands (patients who are disoriented, have a severe neurologic or psychiatric condition).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mayo Clinic in Rochester

Rochester, Minnesota, 55905, United States

Location

Related Links

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Roberto P Benzo

    Mayo Clinic

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 17, 2020

First Posted

July 21, 2020

Study Start

March 22, 2021

Primary Completion

July 30, 2021

Study Completion

July 30, 2021

Last Updated

July 8, 2022

Record last verified: 2022-07

Data Sharing

IPD Sharing
Will not share

Locations